


{"ok":true,"api":{"name":"SAIMSARA Evidence Object Discovery API","version":"v1"},"mode":"doc_key","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"object":{"object_type":"saimsara_evidence_object_metadata","doc_key":"vascular::EVLA_PM","issue_slug":"vascular","doc_id":"EVLA_PM","title":"Endovenous Laser Ablation for Superficial Venous Reflux and Varicose Veins","doi":"10.62487/saimsaraa7dba350","doi_url":"https://doi.org/10.62487/saimsaraa7dba350","version":"2026-05-22","source_name":"PubMed","article_url":"https://saimsara.com/sessions/evla-20260522-050859-a7dba350/","image_url":"","topic_tags":"Endovenous laser ablation,Varicose veins,Great saphenous vein,Venous insufficiency,Laser therapy,Vein occlusion,Clinical recurrence,Quality of life,Postoperative complications,Tumescent anesthesia","keywords":["Endovenous laser ablation","Varicose veins","Great saphenous vein","Venous insufficiency","Laser therapy","Vein occlusion","Clinical recurrence","Quality of life","Postoperative complications","Tumescent anesthesia"],"metrics":{"included_all":436,"included_original":361,"reference_index":196,"total_participants":909189},"discover_url":"https://saimsara.com/api/v1/discover.php?doc_key=vascular%3A%3AEVLA_PM","paid_evidence_url":"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3AEVLA_PM","price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"payment_methods":["api_key","stripe_checkout","object_grant","x402"],"text_length":23786,"preview":"Results Key finding aligned to the query: The most query-defining finding is that EVLA is consistently represented as an effective minimally invasive treatment for superficial venous reflux, with high anatomical closure, rapid recovery, and durable symptom improvement across multiple venous territories and comparative settings. In randomized evidence, EVLA showed lower clinical recurrence than conventional surgery at 5 years in one GSV trial, 20.9% versus 34.3%, and lower recurrence at 10 years in another unilateral GSV reflux trial, 37% versus 59%, although other long-term trials reported comparable or less favorable same-site recurrence versus high ligation and stripping. EVLA also outperf…","trust_label":"machine_generated_human_reviewed","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"checkout":{"method":"POST","url":"https://saimsara.com/create_checkout_session.php","content_type":"application/x-www-form-urlencoded","params":{"plan":"evidence_object","doc_key":"vascular::EVLA_PM"},"optional_params":{"customer_email":"user@example.com"},"price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"curl_example":"curl -X POST https://saimsara.com/create_checkout_session.php -d \"plan=evidence_object\" -d \"doc_key=vascular::EVLA_PM\" -d \"customer_email=user@example.com\""},"access_after_payment":{"header":"X-SAIMSARA-Payment-Proof","endpoint":"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3AEVLA_PM","curl_example":"curl -H \"X-SAIMSARA-Payment-Proof: YOUR_PAYMENT_PROOF_TOKEN\" \"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3AEVLA_PM\""}}}